Source link : https://www.newshealth.biz/health-news/stem-cell-derived-islets-continue-to-show-benefit-in-t1d/
ORLANDO, Fla — Stem cell–derived beta-cell replacement therapy continues to show benefit in people with type 1 diabetes at a high risk for severe hypoglycemia. Of a total 17 patients who received a full dose of Vertex Pharmaceuticals, Inc.’s investigational allogeneic stem cell–derived, fully differentiated pancreatic islet cell replacement therapy (VX-880), three, thus far, have […]
Author : News Health
Publish date : 2024-07-15 08:28:06
Copyright for syndicated content belongs to the linked Source.